ALB and Alzheimer disease: Therefore lowered serum albumin may act as a drawback of AD progression (Llewellyn et al. 2010a) and may also lead to increased neuroinflammatory AD type pathology as illustrated in Fig. 10 (Galeazzi et al. 2002).